Searched for *.

1. Human unconventional T cells in <em>Plasmodium falciparum</em> infection (Publications)

   Human unconventional T cells in <em>Plasmodium falciparum</em> infection

   Relevance:

   Malaria is an old scourge of humankind and has a large negative impact on the economic development of affected communities. Recent success in malaria control and reduction of mortality seems to have s

2. Activity of novel oral formulations of albendazole and mebendazole against <em>Heligmosomoides polygyrus in vitro</em> and <em>in vivo</em> (Publications)

   Activity of novel oral formulations of albendazole and mebendazole against <em>Heligmosomoides polygyrus in vitro</em> and <em>in vivo</em>

   Relevance:

   Albendazole (ABZ) and mebendazole (MBZ) are the two most commonly used drugs in the treatment of soil-transmitted helminths in humans but their performance is hampered by low solubility and physicoche

3. Assessing the effects of the nursing education reform on the educational environment in Tajikistan: a repeated cross-sectional analysis (Publications)

   Assessing the effects of the nursing education reform on the educational environment in Tajikistan: a repeated cross-sectional analysis

   Relevance:

   Background: A well-functioning education system for family nurses is a priority of the primary health care reform in Tajikistan. In 2015/2016, a baseline study was carried out to measure the education

4. Simulating the council-specific impact of anti-malaria interventions: a tool to support malaria strategic planning in Tanzania (Publications)

   Simulating the council-specific impact of anti-malaria interventions: a tool to support malaria strategic planning in Tanzania

   Relevance:

   INTRODUCTION: The decision-making process for malaria control and elimination strategies has become more challenging. Interventions need to be targeted at council level to allow for changing malaria e

5. Ausbildung junger Afrikaner zu Medizingehilfen in Tanganyika (Publications)

   Ausbildung junger Afrikaner zu Medizingehilfen in Tanganyika

   Relevance:

6. Corrigendum to "LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications... (Publications)

   Corrigendum to "LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation" [J. Pharm. Biomed. Anal. 154 (2018) 263-277]

   Relevance:

7. A genome-wide association study on medulloblastoma (Publications)

   A genome-wide association study on medulloblastoma

   Relevance:

   INTRODUCTION: Medulloblastoma is a malignant embryonal tumor of the cerebellum that occurs predominantly in children. To find germline genetic variants associated with medulloblastoma risk, we conduct

8. Insights from quantitative and mathematical modelling on the proposed 2030 goal for <em>gambiense </em>human African trypanosomiasis (gHAT) (Publications)

   Insights from quantitative and mathematical modelling on the proposed 2030 goal for <em>gambiense </em>human African trypanosomiasis (gHAT)

   Relevance:

9. Phototemtide A, a cyclic lipopeptide heterologously expressed from<em> Photorhabdus temperata </em>Meg1, shows selective antiprotozoal activity (Publications)

   Phototemtide A, a cyclic lipopeptide heterologously expressed from<em> Photorhabdus temperata </em>Meg1, shows selective antiprotozoal activity

   Relevance:

   A new cyclic lipopeptide, phototemtide A (1), was isolated from Escherichia coli expressing the biosynthetic gene cluster pttABC from Photorhabdus temperata Meg1. The structure of 1 was elucidated by

10. Preclinical antimalarial combination study of M5717, a <em>Plasmodium falciparum</em> elongation factor 2 inhibitor, and pyronaridine, a hemozoin... (Publications)

    Preclinical antimalarial combination study of M5717, a <em>Plasmodium falciparum</em> elongation factor 2 inhibitor, and pyronaridine, a hemozoin formation inhibitor

    Relevance:

    Antimalarial drug resistance in the Plasmodium falciparum parasite poses a constant challenge for drug development. To mitigate this risk, new antimalarial medicines should be developed as fixed-dose